Join to view full profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Dr. Tayar is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
SUNY Downstate Health Sciences UniversityFellowship, Rheumatology, 2002 - 2004
Zucker School of Medicine at Hofstra/Northwell at Staten Island University HospitalResidency, Internal Medicine, 1998 - 2002
St Joseph's University Medical SchoolClass of 1997
Virginia Mason Franciscan HealthResidency, Family Medicine
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2028
TN State Medical License 2023 - 2028
TX State Medical License 2008 - 2028
GA State Medical License 2023 - 2027
LA State Medical License 2023 - 2027
MS State Medical License 2023 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Rheumatology
- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ClinicStation, UT MD Anderson Cancer Center, 2013-2015
- Fellow (FACR) American College of Rheumatology
Publications & Presentations
PubMed
- A Case Series of Raynaud's Phenomenon in the Setting of Immune Checkpoint Inhibitors.Yuanteng Jeff Li, Maryam Buni, Jean H Tayar, Huifang Lu, Michael Davies
Journal of Immunotherapy and Precision Oncology. 2026-11-01 - Immune Hallmarks of Recurrent Immune Checkpoint Inhibitor-Mediated Inflammatory Arthritis.Synat Keam, Yuanteng Jeff Li, Yanshuo Chu, Jean H Tayar, Huifang Lu
Cancer Immunology Research. 2026-10-05 - Summary recommendations from the NCI clinical trials planning meeting (CTPM) on advanced cutaneous squamous cell carcinoma in immunosuppressed patients.Shlomo A Koyfman, Julie E Bauman, Mehrdad Mohseni, Moran Amit, Darshana M Dadhania
Journal of the National Cancer Institute. 2026-07-21
Authored Content
- Myositis as an Adverse Event of Immune Checkpoint Blockade for Cancer TherapyMay 2018
- Myositis as an Adverse Event of Immune Checkpoint Blockade for Cancer TherapyMay 2018
Press Mentions
Metastatic Melanoma Survivor Finds Hope in Clinical TrialsAugust 20th, 2019- After My Acute Myeloid Leukemia Treatment, Check-Ups Feel like a ReunionJuly 30th, 2019
LupusMarch 18th, 2016
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: